Vaccines for COVID-19
JS Tregoning, ES Brown… - Clinical & …, 2020 - academic.oup.com
Since the emergence of COVID-19, caused by the SARS-CoV-2 virus at the end of 2019,
there has been an explosion of vaccine development. By 24 September 2020, a staggering …
there has been an explosion of vaccine development. By 24 September 2020, a staggering …
[HTML][HTML] Vaccine impact: Benefits for human health
M Doherty, P Buchy, B Standaert, C Giaquinto… - Vaccine, 2016 - Elsevier
Unlike most drugs, whose benefit is restricted to the individual who takes the drug,
prophylactic vaccines have the potential for far-reaching effects that encompass health …
prophylactic vaccines have the potential for far-reaching effects that encompass health …
Vaccine-associated hypersensitivity
MM McNeil, F DeStefano - Journal of Allergy and Clinical Immunology, 2018 - Elsevier
Information for Category 1 CME Credit Credit can now be obtained, free for a limited time, by
reading the review articles in this issue. Please note the following instructions. Method of …
reading the review articles in this issue. Please note the following instructions. Method of …
ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines–an EAACI‐ARIA position paper
Further to the approval of the Coronavirus disease 2019 (COVID‐19) vaccine BNT162b2,
several severe anaphylaxis cases occured within the first few days of public vaccination. An …
several severe anaphylaxis cases occured within the first few days of public vaccination. An …
Vaccine confidence: the keys to restoring trust
S Badur, M Ota, S Öztürk, R Adegbola… - Human vaccines & …, 2020 - Taylor & Francis
During the 20th century, the discovery of modern vaccines and ensuing mass vaccination
dramatically decreased the incidence of many infectious diseases and in some cases …
dramatically decreased the incidence of many infectious diseases and in some cases …
Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: position statement of the German allergy societies …
L Klimek, N Novak, E Hamelmann, T Werfel… - Allergo journal …, 2021 - Springer
Two employees of the National Health Service (NHS) in England developed severe allergic
reactions following administration of BNT162b2 vaccine against COVID-19 (coronavirus …
reactions following administration of BNT162b2 vaccine against COVID-19 (coronavirus …
[HTML][HTML] Vaccine strategies: Optimising outcomes
K Hardt, P Bonanni, S King, JI Santos, M El-Hodhod… - Vaccine, 2016 - Elsevier
Successful immunisation programmes generally result from high vaccine effectiveness and
adequate uptake of vaccines. In the development of new vaccination strategies, the structure …
adequate uptake of vaccines. In the development of new vaccination strategies, the structure …
Impact of widespread introduction of pneumococcal conjugate vaccines on pneumococcal and nonpneumococcal otitis media
S Ben-Shimol, N Givon-Lavi, E Leibovitz… - Clinical Infectious …, 2016 - academic.oup.com
Abstract Background. Pneumococcal conjugated vaccines (PCVs) impact on complex otitis
media (OM; including recurrent, nonresponsive, and chronic OM with effusion) was greater …
media (OM; including recurrent, nonresponsive, and chronic OM with effusion) was greater …
Interventions to help people understand community immunity: A systematic review
Background Herd immunity, or community immunity, occurs when susceptible people in a
population are indirectly protected from infection thanks to the pervasiveness of immunity …
population are indirectly protected from infection thanks to the pervasiveness of immunity …
Estimating the impact of implementation and timing of the COVID-19 vaccination programme in Brazil: a counterfactual analysis
Background Vaccines developed between 2020 and 2021 against the SARS-CoV-2 virus
were designed to diminish the severity and prevent deaths due to COVID-19. However …
were designed to diminish the severity and prevent deaths due to COVID-19. However …